Veronica L Irvin1, Robert M Kaplan2. 1. College of Public Health and Human Sciences, School of Social & Behavioral Health Sciences, Oregon State University, 457 Waldo Hall, Corvallis, OR, 97331, USA. Veronica.irvin@oregonstate.edu. 2. Agency for Healthcare Research and Quality, US Department of Health and Human Services, Rockville, MD, USA.
Abstract
PURPOSE: We reviewed large-budget, National Institutes of Health (NIH)-supported randomized controlled trials (RCTs) with behavioral interventions to assess (1) publication rates, (2) trial registration, (3) use of objective measures, (4) significant behavior and physiological change, and (5) effect sizes. METHODS: We identified large-budget grants (>$500,000/year) funded by NIH (National Heart Lung and Blood Institute (NHLBI) or National Institute of Diabetes & Digestive and Kidney Diseases (NIDDK)) for cardiovascular disease (dates January 1, 1980 to December 31, 2012). Among 106 grants that potentially met inclusion criteria, 20 studies were not published and 48 publications were excluded, leaving 38 publications for analysis. ClinicalTrials.gov abstracts were used to determine whether outcome measures had been pre-specified. RESULTS: Three fourths of trials were registered in ClinicalTrials.gov and all published pre-specified outcomes. Twenty-six trials reported a behavioral outcome with 81 % reporting significant improvements for the target behavior. Thirty-two trials reported a physiological outcome. All were objectively measured, and 81 % reported significant benefit. Seventeen trials reported morbidity outcomes, and seven reported a significant benefit. Nine trials assessed mortality, and all were null for this outcome. CONCLUSIONS: Behavioral trials complied with trial registration standards. Most reported a physiological benefit, but few documented morbidity or mortality benefits.
PURPOSE: We reviewed large-budget, National Institutes of Health (NIH)-supported randomized controlled trials (RCTs) with behavioral interventions to assess (1) publication rates, (2) trial registration, (3) use of objective measures, (4) significant behavior and physiological change, and (5) effect sizes. METHODS: We identified large-budget grants (>$500,000/year) funded by NIH (National Heart Lung and Blood Institute (NHLBI) or National Institute of Diabetes & Digestive and Kidney Diseases (NIDDK)) for cardiovascular disease (dates January 1, 1980 to December 31, 2012). Among 106 grants that potentially met inclusion criteria, 20 studies were not published and 48 publications were excluded, leaving 38 publications for analysis. ClinicalTrials.gov abstracts were used to determine whether outcome measures had been pre-specified. RESULTS: Three fourths of trials were registered in ClinicalTrials.gov and all published pre-specified outcomes. Twenty-six trials reported a behavioral outcome with 81 % reporting significant improvements for the target behavior. Thirty-two trials reported a physiological outcome. All were objectively measured, and 81 % reported significant benefit. Seventeen trials reported morbidity outcomes, and seven reported a significant benefit. Nine trials assessed mortality, and all were null for this outcome. CONCLUSIONS: Behavioral trials complied with trial registration standards. Most reported a physiological benefit, but few documented morbidity or mortality benefits.
Entities:
Keywords:
Behavior; Cardiovascular; Effect sizes; Intervention; Periodicals as topics/statistics; Publication statistics; Randomized controlled trials as topics/statistics; Trial registration
Authors: Jennifer S Lin; Elizabeth O'Connor; Corinne V Evans; Caitlyn A Senger; Maya G Rowland; Holly C Groom Journal: Ann Intern Med Date: 2014-10-21 Impact factor: 25.391
Authors: David W Baker; Darren A Dewalt; Dean Schillinger; Victoria Hawk; Bernice Ruo; Kirsten Bibbins-Domingo; Morris Weinberger; Aurelia Macabasco-O'Connell; Kathy L Grady; George M Holmes; Brian Erman; Kimberly A Broucksou; Michael Pignone Journal: J Card Fail Date: 2011-07-23 Impact factor: 5.712
Authors: Lawrence J Appel; Catherine M Champagne; David W Harsha; Lawton S Cooper; Eva Obarzanek; Patricia J Elmer; Victor J Stevens; William M Vollmer; Pao-Hwa Lin; Laura P Svetkey; Sarah W Stedman; Deborah R Young Journal: JAMA Date: 2003 Apr 23-30 Impact factor: 56.272
Authors: Liliana E Pezzin; Penny H Feldman; Jennifer M Mongoven; Margaret V McDonald; Linda M Gerber; Timothy R Peng Journal: J Gen Intern Med Date: 2010-10-13 Impact factor: 5.128
Authors: R Stamler; J Stamler; R Grimm; F C Gosch; P Elmer; A Dyer; R Berman; J Fishman; N Van Heel; J Civinelli Journal: JAMA Date: 1987-03-20 Impact factor: 56.272
Authors: Michael G Perri; Marian C Limacher; Patricia E Durning; David M Janicke; Lesley D Lutes; Linda B Bobroff; Martha Sue Dale; Michael J Daniels; Tiffany A Radcliff; A Daniel Martin Journal: Arch Intern Med Date: 2008-11-24
Authors: Darren A DeWalt; Dean Schillinger; Bernice Ruo; Kirsten Bibbins-Domingo; David W Baker; George M Holmes; Morris Weinberger; Aurelia Macabasco-O'Connell; Kimberly Broucksou; Victoria Hawk; Kathleen L Grady; Brian Erman; Carla A Sueta; Patricia P Chang; Crystal Wiley Cene; Jia-Rong Wu; Christine D Jones; Michael Pignone Journal: Circulation Date: 2012-05-09 Impact factor: 29.690
Authors: Alena Kuhlemeier; Thomas Jaki; Elizabeth Y Jimenez; Alberta S Kong; Hope Gill; Chi Chang; Ken Resnicow; Dawn K Wilson; M Lee Van Horn Journal: J Behav Med Date: 2022-01-15